Portfolio Design Labs LLC Invests $266,000 in The Allstate Co. (NYSE:ALL)

Portfolio Design Labs LLC purchased a new position in shares of The Allstate Co. (NYSE:ALL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,381 shares of the insurance provider's stock, valued at approximately $266,000.

Other large investors also recently bought and sold shares of the company. Peterson Wealth Services boosted its stake in shares of Allstate by 8.5% in the fourth quarter. Peterson Wealth Services now owns 1,379 shares of the insurance provider's stock worth $266,000 after acquiring an additional 108 shares during the last quarter. Axecap Investments LLC lifted its holdings in Allstate by 5.7% in the 4th quarter. Axecap Investments LLC now owns 18,879 shares of the insurance provider's stock valued at $3,640,000 after purchasing an additional 1,010 shares in the last quarter. Stonebridge Financial Group LLC acquired a new stake in shares of Allstate in the fourth quarter valued at about $53,000. Essex Financial Services Inc. raised its position in shares of Allstate by 2.8% in the fourth quarter. Essex Financial Services Inc. now owns 9,188 shares of the insurance provider's stock valued at $1,771,000 after buying an additional 250 shares during the last quarter. Finally, Sapient Capital LLC raised its position in shares of Allstate by 1.6% in the fourth quarter. Sapient Capital LLC now owns 4,543 shares of the insurance provider's stock valued at $880,000 after buying an additional 73 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Allstate Trading Down 2.7 %

Shares of NYSE ALL traded down $5.24 during trading on Friday, reaching $187.53. The stock had a trading volume of 3,917,486 shares, compared to its average volume of 1,603,816. The Allstate Co. has a fifty-two week low of $153.87 and a fifty-two week high of $209.88. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The business's 50-day moving average price is $190.91 and its 200-day moving average price is $189.74. The company has a market cap of $49.66 billion, a P/E ratio of 11.04, a PEG ratio of 1.47 and a beta of 0.52.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. On average, equities research analysts predict that The Allstate Co. will post 18.64 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Jesse E. Merten sold 40,102 shares of the company's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares of the company's stock, valued at $3,378,990.95. This represents a 68.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.80% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

ALL has been the subject of several research reports. Wells Fargo & Company upped their price objective on shares of Allstate from $186.00 to $187.00 and gave the company an "equal weight" rating in a research note on Tuesday, January 14th. Jefferies Financial Group boosted their target price on Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Morgan Stanley lifted their price objective on Allstate from $220.00 to $228.00 and gave the stock an "overweight" rating in a research report on Thursday, November 7th. Evercore ISI upgraded Allstate from an "in-line" rating to an "outperform" rating in a report on Wednesday, January 8th. Finally, UBS Group lifted their price target on Allstate from $216.00 to $225.00 and gave the stock a "buy" rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $217.94.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.